Hepatitis A is a temporary liver infection caused by the hepatitis A virus. Symptoms include diarrhea, dark urine, fatigue, fever, nausea, vomiting, pain, and jaundice, yellowing of the eyes and skin.

With NIH funding, the group will pursue research and patient care approaches for a disease that affects more than 250 million people around the globe ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. LEWISTON — Looking back, Rosie Boyce does not recall experiencing many ...

Chronic hepatitis D virus (HDV) coinfection in people with chronic hepatitis B is associated with rapid progression to liver ...

JHU BME’s Winston Timp is leading the Multiomics Core for a new $24M NIH initiative to find a Hepatitis B cure.

Researchers suggest adding a new drug boceprevir to a two-drug treatment can enhance outcomes for hepatitis C patients, according to a USA Today news report. The drugs currently used to treat ...

According to the Centers for Disease Control and Prevention, more than 2 million people in the U.S. are infected with hepatitis C. The bloodborne illness attacks the liver and can lead to cancer or ...

That unexplained fatigue dragging you down for weeks. The slight yellowing around your eyes that you blamed on poor lighting. The vague abdominal discomfort you’ve been treating with over-the-counter ...

Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and ...